Free heme toxicity and its detoxification systems in human

被引:665
作者
Kumar, S [1 ]
Bandyopadhyay, U [1 ]
机构
[1] Cent Drug Res Inst, Div Drug Target Discovery & Dev, Lucknow 226001, Uttar Pradesh, India
关键词
toxicity; heme; heme detoxification; reactive oxygen species; inflammation;
D O I
10.1016/j.toxlet.2005.03.004
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Severe hemolysis or myolysis occurring during pathological states, such as sickle cell disease, ischemia reperfusion, and malaria results in high levels of free heme, causing undesirable toxicity leading to organ, tissue, and cellular injury. Free heme catalyzes the oxidation, covalent cross-linking and aggregate formation of protein and its degradation to small peptides. It also catalyzes the formation of cytotoxic lipid peroxide via lipid peroxiclation and damages DNA through oxidative stress. Heme being a lipophilic molecule intercalates in the membrane and impairs lipid bilayers and organelles, such as mitochondria and nuclei, and destabilizes the cytoskeleton. Heme is a potent hemolytic agent and alters the conformation of cytoskeletal protein in red cells. Free heme causes endothelial cell injury, leading to vascular inflammatory disorders and stimulates the expression of intracellular adhesion molecules. Heme acts as a pro-inflammatory molecule and heme-induced inflammation is involved in the pathology of diverse conditions; such as renal failure, arteriosclerosis, and complications after artificial blood transfusion, peritoneal endometriosis, and heart transplant failure. Herne offers severe toxic effects to kidney, liver, central nervous system and cardiac tissue. Although heme oxygenase is primarily responsible to detoxify free heme but other extra heme oxygenase systems also play a significant role to detoxify heme. A brief account of free heme toxicity and its detoxification systems along with mechanistic details are presented. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 188
页数:14
相关论文
共 115 条
[61]  
LIU SC, 1985, J BIOL CHEM, V260, P2234
[62]   Heme and acute inflammation -: Role in vivo of heme in the hepatic expression of positive acute-phase reactants in rats [J].
Lyoumi, S ;
Puy, H ;
Tamion, F ;
Bogard, C ;
Leplingard, A ;
Scotté, M ;
Vranckx, R ;
Gauthier, F ;
Hiron, M ;
Daveau, M ;
Nordmann, Y ;
Deybach, JC ;
Lebreton, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 261 (01) :190-196
[63]   The heme oxygenase system: A regulator of second messenger gases [J].
Maines, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :517-554
[64]   HEME OXYGENASE - FUNCTION, MULTIPLICITY, REGULATORY MECHANISMS, AND CLINICAL-APPLICATIONS [J].
MAINES, MD .
FASEB JOURNAL, 1988, 2 (10) :2557-2568
[65]  
Maines MD, 2000, CELL MOL BIOL, V46, P573
[66]  
MARTASEK P, 1991, J AM SOC NEPHROL, V2, P1078
[67]   Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene [J].
Melo, LG ;
Agrawal, R ;
Zhang, LN ;
Rezvani, M ;
Mangi, AA ;
Ehsan, A ;
Griese, DP ;
Dell'Acqua, G ;
Mann, MJ ;
Oyama, J ;
Yet, SF ;
Layne, MD ;
Perrella, MA ;
Dzau, VJ .
CIRCULATION, 2002, 105 (05) :602-607
[68]  
MILLER YI, 1994, BIOCHEM MOL BIOL INT, V34, P1121
[69]   CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response [J].
Moestrup, SK ;
Moller, HJ .
ANNALS OF MEDICINE, 2004, 36 (05) :347-354
[70]   PLASMA CONCENTRATIONS OF HEMOPEXIN HAPTOGLOBIN AND HEME IN PATIENTS WITH VARIOUS HEMOLYTIC DISEASES [J].
MULLEREBERHARD, U ;
JAVID, J ;
LIEM, HH ;
HANSTEIN, A ;
HANNA, M .
BLOOD, 1968, 32 (05) :811-+